PTI - Proteostasis Therapeutics - Stock Forecast

Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

Proteostasis Therapeutics's activity chart (see below) currently has 14 price targets and 12 ratings on display.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 88.89% with an average time for these price targets to be met of 469.56 days.

Most recent stock forecast was given by from PIPER SANDLER on 24-Aug-2020. First documented stock forecast 12-Aug-2016.

Best performing analysts who are covering PTI - Proteostasis Therapeutics:

Brian Abrahams Elemer Piros Edward Tenthoff Joseph Schwartz Kristen Kluska

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Buy Since 18-Oct-2018

$8

$-146.7 (-94.83%)

$8

Buy Since 06-Nov-2018

$14

$-140.7 (-90.95%)

$21

Show more analysts

Please expand the browser size to see the chart

What is PTI (Proteostasis Therapeutics) average time for price targets to be met?

On average it took 469.56 days on average for the stock forecasts to be realized with a an average price target met ratio 88.89

Which analyst has the current highest performing score on PTI (Proteostasis Therapeutics) with a proven track record?

BRIAN ABRAHAMS

Which analyst has the most public recommendations on PTI (Proteostasis Therapeutics)?

Brian Abrahams works at RBC and has 37 price targets and 24 ratings on PTI

Which analyst is the currently most bullish on PTI (Proteostasis Therapeutics)?

Edward Tenthoff with highest potential upside - $0

Which analyst is the currently most reserved on PTI (Proteostasis Therapeutics)?

Kristen Kluska with lowest potential downside - -$150.7

To continue looking at which analysts cover the stock please register to the basic or advanced membership

To continue looking at analysts data please register to the advanced membership

What is AnaChart?